← Back to guidelines
Dermatology5 papers

Malignant keratoacanthoma

Last edited: 4/10/2026

Overview

Keratoacanthoma (KA) is a common, rapidly growing, low-grade squamous cell carcinoma that typically presents as a dome-shaped nodule with a central keratin plug 1. While most KAs are benign and resolve spontaneously, a subset can exhibit aggressive behavior, invade locally, metastasize, or arise in the context of pre-existing skin conditions with malignant potential 1.

Diagnosis

  • Rapidly growing, dome-shaped nodule with a central keratin plug 1.
  • Histopathological examination is crucial for definitive diagnosis and to rule out invasive squamous cell carcinoma 1.
  • Management

  • Surgical excision is the primary treatment for most keratoacanthomas 1.
  • Other treatment modalities include intralesional chemotherapy, radiation therapy, and topical agents, particularly for larger or recurrent lesions 1.
  • For porokeratosis ptychotropica with suspected malignant transformation, topical lovastatin/cholesterol cream has shown promise 1.
  • Key Recommendations

  • Surgical excision is the primary treatment for keratoacanthoma 1. (Evidence: Expert opinion)
  • Long-term surveillance is recommended for patients with porokeratosis ptychotropica due to the risk of malignant transformation 1. (Evidence: Expert opinion)
  • References

    1 Loh CH, Tan CL, Tan KB, Sudhoff H, Goon P. Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review. Acta dermato-venereologica 2024. link

    Original source

    1. [1]
      Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.Loh CH, Tan CL, Tan KB, Sudhoff H, Goon P Acta dermato-venereologica (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG